首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1619094

幹細胞市場規模、佔有率、成長分析、按產品、按應用、按技術、按治療方法、按最終用途、按地區 - 行業預測，2024-2031 年

Stem Cell Market Size, Share, Growth Analysis, By Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs)), By Application (Regenerative Medicine), By Technology, By Therapy, By End-Use and By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 275 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022 年全球幹細胞市場規模為 119 億美元，從 2023 年的 133 億美元成長到 2031 年的 316 億美元，在預測期間（2024-2031 年）複合年成長率為 11.4%。

在全球臨床試驗數量不斷增加和創新治療方法採用的推動下，全球幹細胞市場預計將顯著成長。 COVID-19 大流行引發了人們對幹細胞療法的興趣，其在免疫調節療法和正在進行的研究中具有廣泛的應用前景。 Cellino Biotech 為提高這些治療方法的可及性而提供的 8,000 萬美元資金籌措就是一項重大投資，展現了商業性進展的潛力。為澳洲創新幹細胞計劃提供 590 萬美元資金等政府舉措進一步推動了市場擴張。然而，挑戰依然存在，例如高成本和道德困境。儘管存在這些障礙，對再生醫學不斷成長的需求和持續的研究工作為幹細胞領域的成長和機會帶來了光明的前景，使公司和患者都受益。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Thermo Fisher Scientific, Inc.
STEMCELL Technologies Inc.
Merck KGaA
CellGenix GmbH
PromoCell GmbH
Takara Holdings, Inc.
Lonza
Cellular Engineering Technologies
ATCC
AcceGen
Cell Applications, Inc.
Bio-Techne
Organogenesis
FUJIFILM Cellular Dynamics
Gamida Cell
GE Healthcare
Pluristem Therapeutics
Cynata Therapeutics
Smith+Nephew
Medipost

結論和建議

簡介目錄

Product Code: SQMIG35D2059

Global Stem Cell Market size was valued at USD 11.9 billion in 2022 and is poised to grow from USD 13.3 billion in 2023 to USD 31.6 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).

The global stem cell market is poised for substantial growth, propelled by an increase in clinical trials and the adoption of innovative therapies worldwide. The COVID-19 pandemic has heightened interest in stem cell treatments, with promising applications in immunomodulation therapies leading to ongoing studies. Significant investments, exemplified by Cellino Biotech's USD 80 million funding to enhance access to these therapies, underline the potential for commercial advancements. Government initiatives, such as Australia's USD 5.9 million funding for innovative stem cell projects, further support market expansion. However, challenges including high costs and ethical dilemmas persist. Despite these hurdles, the rising demand for regenerative medicine and ongoing research efforts present a promising landscape for growth and opportunities in the stem cell sector, benefitting both businesses and patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Market Segmental Analysis

Global Stem Cell Market is segmented by Product, Application, Technology, Therapy, End-Use and Region. Based on Product, the market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells. Based on Application, the market is segmented into Regenerative Medicine, Cardiovascular and Myocardial Infraction, Drug Discovery and Development. Based on Technology, the market is segmented into Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture. Based on Therapy, the market is segmented into Autologous, Allogeneic. Based on End-Use, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Market

One of the primary drivers of the global stem cell market is the escalating incidence of chronic diseases, including cancer, diabetes, and cardiovascular conditions. This rise in health issues is fueling a growing demand for stem cell therapies, which are being explored as effective treatment alternatives. For example, stem cell therapy for knee pain, particularly due to osteoarthritis, has emerged as a promising non-surgical solution. As more patients seek these innovative therapeutic options to combat chronic ailments, the stem cell market is anticipated to experience considerable expansion, highlighting the pivotal role of stem cell treatments in modern medicine.

Restraints in the Global Stem Cell Market

A significant challenge facing the global stem cell market is the elevated cost linked to stem cell therapies, such as transplants, injections, and various treatments. These high expenses act as a barrier to widespread adoption, especially in developing nations where financial resources may be limited. Consequently, numerous patients find themselves unable to afford these advanced treatments, which in turn hinders the overall growth potential of the market. The affordability issue underscores the need for more accessible solutions and pricing models to enhance patient access and foster broader utilization of stem cell therapies.

Market Trends of the Global Stem Cell Market

The global stem cell market is witnessing a significant trend towards personalized medicine, reshaping therapeutic approaches across various medical conditions. The customization of stem cell therapies to cater to individual patient profiles - including genetic makeup and medical histories - is becoming prevalent, particularly in treatments for knee ailments and other disorders. This evolution is propelled by groundbreaking advancements in stem cell research and technology, which are facilitating the creation of tailored treatments that maximize efficacy and improve patient outcomes. As healthcare shifts towards more individualized approaches, the demand for personalized stem cell therapies is expected to escalate, positioning this segment for substantial growth in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Assessment
Regulatory Landscape
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology
Patent Analysis

Global Stem Cell Market Size by Product & CAGR (2024-2031)

Market Overview
Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Others
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (IPSCs)
Very Small Embryonic Like Stem Cells

Global Stem Cell Market Size by Application & CAGR (2024-2031)

Market Overview
Regenerative Medicine
- Neurology
- Orthopaedics
- Oncology
- Haematology
Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
Drug Discovery and Development

Global Stem Cell Market Size by Technology & CAGR (2024-2031)

Market Overview
Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Global Stem Cell Market Size by Therapy & CAGR (2024-2031)

Market Overview
Autologous
Allogeneic

Global Stem Cell Market Size by End-Use & CAGR (2024-2031)

Market Overview
Pharmaceutical and Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes

Global Stem Cell Market Size & CAGR (2024-2031)

North America (Product, Application, Technology, Therapy, End-Use)
- US
- Canada
Europe (Product, Application, Technology, Therapy, End-Use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Application, Technology, Therapy, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Application, Technology, Therapy, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Technology, Therapy, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellGenix GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellular Engineering Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATCC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AcceGen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Applications, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Cellular Dynamics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gamida Cell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluristem Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cynata Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medipost
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments